Movement Disorders (revue) - Analysis (France)

Index « Auteurs » - entrée « Gabriel Villafane »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Gabriel Robert < Gabriel Villafane < Gabrielle Rudolf  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 2.
Ident.Authors (with country if any)Title
000206 (2010) Olivier Rascol [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France] ; Anne-Marie Bonnet [France] ; Christine Brefel-Courbon [France] ; Pierre Césaro [France] ; Philippe Damier [France] ; Bérengère Debilly [France] ; Frank Durif [France] ; Monique Galitzky [France] ; Jean-Marie Grouin [France] ; Sylvie Pennaforte [France] ; Gabriel Villafane [France] ; Sadek Yaici [France] ; Yves Agid [France]Orodispersible sublingual piribedil to abort OFF episodes: A single dose placebo‐controlled, randomized, double‐blind, cross‐over study
000445 (2003) Valérie Cochen [France] ; Maria-Joao Ribeiro [France] ; Jean-Paul Nguyen [France] ; Jean-Marc Gurruchaga [France] ; Gabriel Villafane [France] ; Christian Loc'H [France] ; Gilles Defer [France] ; Yves Samson [France] ; Marc Peschanski [France] ; Philippe Hantraye [France] ; Pierre Cesaro [France] ; Philippe Remy [France]Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue

List of associated KwdEn.i

Nombre de
documents
Descripteur
2Humans
2Parkinson disease
1Administration, Sublingual
1Adult
1Aged
1Antiparkinson Agents (administration & dosage)
1Apomorphine (administration & dosage)
1Autograft
1Biological transport
1CIT
1Cell therapy
1Corpus Striatum (metabolism)
1Cross-Over Studies
1Dopamine
1Dopamine Plasma Membrane Transport Proteins
1Dopamine agonist
1Dose-Response Relationship, Drug
1Double blind study
1Double-Blind Method
1Drug Administration Routes
1Female
1Fetal Tissue Transplantation (methods)
1Fetal cell
1Fluctuations
1Fluorodeoxyglucose F18 (diagnostic use)
1Fluorodeoxyglucose F18 (pharmacokinetics)
1France
1Graft Rejection (prevention & control)
1Immunosuppressive Agents (therapeutic use)
1Ligand
1Logistic Models
1Male
1Mechanism of action
1Membrane Glycoproteins
1Membrane Transport Proteins (metabolism)
1Mesencephalon (embryology)
1Mesencephalon (metabolism)
1Mesencephalon (transplantation)
1Midbrain
1Middle Aged
1Nerve Tissue Proteins
1Nervous system diseases
1PET
1Parkinson
1Parkinson Disease (diagnosis)
1Parkinson Disease (drug therapy)
1Parkinson Disease (surgery)
1Parkinson's disease
1Piribedil
1Piribedil (administration & dosage)
1Placebo
1Positron emission tomography
1Proportional Hazards Models
1Radiopharmaceuticals (diagnostic use)
1Radiopharmaceuticals (pharmacokinetics)
1S90049
1Severity of Illness Index
1Single dose
1Tomography, Emission-Computed
1Treatment
1apomorphine
1dopamine agonist
1dopamine transporter
1fetal transplantation
1motor fluctuations
1piribedil

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Gabriel Villafane" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Gabriel Villafane" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Gabriel Villafane
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024